...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Benefits and risks of emerging genetic technologies: the need for regulation.
【24h】

Benefits and risks of emerging genetic technologies: the need for regulation.

机译:新兴遗传技术的利益和风险:监管的需求。

获取原文

摘要

Efforts to localize human genes to specific chromosomes and then to identify these genes and their role in specific diseases are increasing. These developments will expand the repertoire of genetic tests that are claimed to be predictive of future disease in the person being tested (pre-symptomatic tests) or in future offspring of those being tested (tests for reproductive options). In single-gene (mendelian) disorders, such tests may fail to detect all of the alleles capable of causing disease. In multifactorial disorders, positive results of tests for specific alleles will not always predict future disease because the other necessary factors may be absent. Policies are already in place to provide safe and effective clinical laboratory tests and interventions for subjects with positive test results, and to assure the quality of the laboratories performing such tests, but are not widely known or enforced for genetic tests.
机译:将人类基因定位到特定染色体,然后鉴定这些基因及其在特定疾病中的作用的努力正在增加。这些发展将扩大基因测试的范围,据称这些基因测试可以预测被测人(症状前测试)或被测人的未来后代(生殖选择测试)的未来疾病。在单基因(孟德尔)疾病中,此类检测可能无法检测到所有可能引起疾病的等位基因。在多因素疾病中,特定等位基因检测的阳性结果并不总是可以预测未来的疾病,因为其他必要因素可能不存在。已经有政策为测试结果呈阳性的受试者提供安全有效的临床实验室测试和干预措施,并确保执行此类测试的实验室的质量,但是对于基因测试并未广为人知或强制执行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号